"The injury is extremely rare, but we do know that because children...
Category:
Health
Latest
Cholamandalam MS Insurance appointed as lead insurer for West Bengal
Chennai based Cholamandalam MS Insurance has been appointed lead...
WMO warns of risk of heart attacks, deaths as heatwave intensifies
The WMO has said the extreme weather looks likely to become the...
Fully vaccinated people will no longer be required to quarantine after Covid exposure
“Fully vaccinated persons who meet criteria will no longer be required to quarantine following an exposure to someone with Covid-19,” the CDC said.
Bihar’s Covid data fudge: CM Nitish Kumar accepts negligence in testing
Meanwhile, Vice President and speaker of Rajya Sabha M. Venkaiah Naidu said that it is a serious matter. He also recommended Union Health Minister Harsh Vardhan to initiate an investigation in this matter.
Govt finalises rules under 4 labour codes, reform to be a reality soon
Parliament had passed four codes on four broad codes on wages, industrial relations, social security and occupational safety health & working conditions (OSH) which would ultimately rationalise 44 central labour laws.
Labour Secretary Apurva Chandra said, “We have finalised the rules under the four codes which are required to implement the four labour codes. We are ready to notify these rules. The states are doing their work to firm up rules under the four codes.”
7.3 magnitude quake rattles East Japan, No Tsunami risk
Images posted online showed broken glass at a shop and items spilled off the shelves at a supermarket.
Renowned author Yu Miri, who lives in Fukushima’s Minamisoma city, tweeted a photo of her home, showing books, potted plants and other belongings strewn across the floor.
COVID-19: Centre issues fresh SOPs, allows offices to resume work after disinfection
Staff should take their temperature regularly and check for respiratory symptoms and must see a doctor if they feel unwell or show flu-like symptoms. Besides, staff and waiters should wear mask and hand gloves and take other required precautionary measures. The seating arrangement has to be done to ensure a distance of at least six feet, the SOPs stated.
Virus may never go away but could change into mild annoyance
If humans must learn to live with Covid-19, the nature of that coexistence depends not just on how long immunity lasts, but also how the virus evolves. Will it mutate significantly each year, requiring annual shots, like the flu? Or will it pop up every few years?
Anti-clotting therapy may prevent death in Covid-19 patients
Clinical trials are now underway to see if prophylactic anticoagulants could be an effective treatment for COVID-19. In the meantime, the researchers say these findings provide strong real-world evidence to support their early use among patients in hospitals with Covid-19.
India’s national recovery rate among highest in the world: Health ministry
“India’s Covid-19 recovery rate of 97.31 per cent is amongst the highest in the world. The difference between the recovered and active cases has grown to 1,04,74,164 as on date,” the ministry highlighted.
Till date, the cumulative number of healthcare and frontline workers vaccinated against Covid-19 in the country has surpassed 82 lakhs.
Indian drugmaker to pay $50mn in fine for destroying records before FDA inspection
“Pharmaceutical companies that obstruct FDA inspections jeopardise patient safety,” said US Attorney Nicholas A. Trutanich for the District of Nevada.
Investors vie for windfall from rejected covid insurance claims
Distressed-investing funds and litigation-finance boutiques are likely to be spoiled for choice after a landmark U.K. court ruling last month rejected pleas from insurers looking to dodge pandemic payouts. They’re looking to finance or buy denied Covid-19 insurance claims for policyholders without the means or stomach for taking their insurers to court.
“This is going to be huge,” said Steve Cooklin, chief executive officer of London-based litigation funder Manolete Partners Plc, whose biggest shareholder is veteran distressed investor Jon Moulton.